Aligning Administration Group given New Refined Business Give attention to Establishments Beginning with Current Appointment of Board Member Zhenya Lindgardt as Interim President and CEO

Engages Main Technique Home to Consider Finest Pathways Towards Concentrating on Enhanced Income Technology at Considerably Lowered Working Prices

Nadia Altomare Anticipated to Transfer from Chief Business Officer to Consulting Position to Assist Driving Effectivity and Effectiveness in Our Business Spend in Partnership with Our Exterior and Inside Group

SALT LAKE CITY, Could 25, 2023 /PRNewswire/ — Sera Prognostics Inc., The Being pregnant Firm® (NASDAQ: SERA), targeted on bettering maternal and neonatal well being by offering progressive being pregnant biomarker info to medical doctors and sufferers, at this time introduced sure business adjustments and plans to optimize its technique and business construction to extremely focus enterprise actions on accelerating check adoption and income at considerably lowered working prices.

These plans embody adjustments to higher align management with a brand new refined business deal with establishments and cost-effectively accelerating check adoption and income upfront of upcoming information readouts. This course of began with the current appointment of Board Member Zhenya Lindgardt, a seasoned enterprise operator for high-growth organizations, as interim President and CEO, introduced on Could 15, 2023.  

Sera Prognostics has additionally engaged a number one technique home to carefully consider one of the best pathways towards enhanced income at considerably lowered price to extra broadly commercialize the corporate’s PreTRM® Take a look at and pipeline of know-how. This analysis is predicted to be inclusive of environment friendly market focus and potential strategic partnerships. As a part of this course of, Nadia Altomare is predicted to maneuver from Chief Business Officer to a consulting position to assist driving effectivity and effectiveness in our business spend in partnership with our exterior and inside workforce.

The Firm has additionally made choose headcount reductions at month finish in its business group to higher map present business and advertising prices towards refined deal with these alternatives being deemed as probably the most profitable within the near-term from a check adoption and income era perspective. Sera Prognostics is evaluating different methods to additional optimize its enterprise whereas lowering working prices and defending its robust steadiness sheet, which presently affords a robust basis towards realization of the Firm’s objectives outlined at this time coupled with focusing on improved shareholder valuation.

“We’re taking decisive and well-defined steps to optimize for market success given the macro atmosphere, whereas additionally making an allowance for the rising position we search to play in establishing our first-of-its-kind PreTRM check as a typical of care in defending moms and infants,” stated Sera Prognostics interim CEO, Zhenya Lindgardt. “Whereas change is at occasions difficult, we anticipate our actions will show profitable in supporting our purpose to be The Being pregnant Firm whereas fostering important progress, and we’re grateful for our workforce’s position in making a paradigm shift in being pregnant care to create higher healthcare outcomes for expectant moms and their youngsters.”

About Sera Prognostics, Inc.

Sera Prognostics is a number one well being diagnostics firm devoted to bettering the lives of girls and infants by means of precision being pregnant care. Sera’s mission is to supply early, pivotal being pregnant info to enhance the well being of moms and newborns, leading to reductions within the prices of healthcare supply. Sera has a sturdy pipeline of progressive diagnostic assessments targeted on the early prediction of preterm start threat and different issues of being pregnant. Sera’s precision drugs PreTRM® Take a look at reviews to a doctor the individualized threat of spontaneous untimely supply in a being pregnant, enabling earlier proactive interventions in ladies with increased threat. Sera Prognostics is situated in Salt Lake Metropolis, Utah.

About Preterm Start

Preterm start is outlined as any start earlier than 37 weeks’ gestation and is the main explanation for sickness and dying in newborns. The 2022 March of Dimes Report Card exhibits that, for the final 4 consecutive years, multiple in ten infants is born prematurely. Prematurity is related to a considerably elevated threat of main long-term medical issues, together with studying disabilities, cerebral palsy, persistent respiratory sickness, mental incapacity, seizures, and imaginative and prescient and listening to loss, and might generate important prices all through the lives of affected youngsters. The annual well being care prices to handle short- and long-term issues of prematurity in america have been estimated to be roughly $25 billion for 2016.

In regards to the PreTRM® Take a look at

The PreTRM® Take a look at is the one broadly validated, commercially obtainable blood-based biomarker check that gives an early, correct and individualized threat prediction for spontaneous preterm start in asymptomatic singleton pregnancies. The PreTRM® Take a look at measures and analyzes proteins within the blood which are extremely predictive of preterm start. The PreTRM® Take a look at permits physicians to determine, throughout the weeks 18 by means of 20 of being pregnant, which ladies are at elevated threat for preterm start and its issues, enabling extra knowledgeable, customized scientific choices primarily based on every girl’s particular person threat. The PreTRM® Take a look at is ordered by a medical skilled.

Sera Prognostics, the Sera Prognostics emblem, The Being pregnant Firm, and PreTRM are logos or registered logos of Sera Prognostics, Inc. in america and/or different nations.

Secure Harbor Assertion

This press launch accommodates “forward-looking statements” throughout the which means of the Non-public Securities Litigation Reform Act of 1995, together with statements regarding accelerating check adoption and income; focusing on enhanced income era at considerably lowered working prices; driving effectivity and effectiveness in our business spend; upcoming information readouts; potential strategic partnerships; additional optimizing the Firm’s enterprise; improved shareholder valuation; establishing the Firm’s first-of-its-kind PreTRM check as a typical of care; fostering important progress; and the corporate’s strategic directives underneath the caption “About Sera Prognostics, Inc.” These “forward-looking statements” are primarily based on administration’s present expectations of future occasions and are topic to a variety of dangers and uncertainties that would trigger precise outcomes to vary materially and adversely from these set forth in or implied by forward-looking statements. These dangers and uncertainties embody, however should not restricted to: internet losses, money era, and the potential want to boost extra capital; revenues from the PreTRM Take a look at representing considerably all Firm revenues thus far; the necessity for broad scientific and market acceptance of the PreTRM Take a look at; a concentrated variety of materials clients; our capacity to introduce new merchandise; potential competitors; our proprietary biobank; essential suppliers; the COVID-19 pandemic and its potential lingering influence on our operations, in addition to the enterprise or operations of third events with whom we conduct enterprise; estimates of complete addressable market alternative and forecasts of market progress; potential third-party payer protection and reimbursement; new reimbursement methodologies relevant to the PreTRM Take a look at, together with new CPT codes and fee charges for these codes; adjustments in FDA regulation of laboratory-developed assessments; the mental property rights defending our assessments and market place; and different elements mentioned underneath the heading “Danger Elements” contained in our Remaining Prospectus on Kind S-1, which was filed with the Securities and Trade Fee on July 14, 2021, in addition to any updates to these threat elements filed infrequently in our Quarterly Stories on Kind 10-Q, Annual Stories on Kind 10-Okay, or Present Stories on Kind 8-Okay. All info on this press launch is as of the date of the discharge, and the Firm undertakes no obligation to replace this info until required by legislation.

SOURCE Sera Prognostics, Inc.

By Editor